REVOLUTION Medicines Funding & Investors
Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.
revolutionmedicines.comTotal Amount Raised: $1,254,400,000
REVOLUTION Medicines Funding Rounds
Series C
$100,000,000
Series C Investors
Boxer CapitalColumn GroupFidelity InvestmentsThird Rock VenturesDeerfield Capital ManagementBiotechnology Value FundVivo CapitalCasdin CapitalCormorant CapitalSchroder AdveqNextech InvestSeries B
$56,000,000
Series B Investors
Nextech InvestCasdin CapitalColumn GroupThird Rock VenturesSchroder AdveqPost Ipo Equity
$323,600,000
Post Ipo Equity
$260,900,000
Post Ipo Equity
$264,500,000
Post Ipo Equity
$179,400,000
Series A
$45,000,000
Series A Investors
Third Rock VenturesSeries A
$25,000,000
Series A Investors
Column GroupThird Rock Ventures
Funding info provided by Diffbot.